PKI 14-22 amide, myristoylated Acetate T21983L
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
PKI 14-22 amide, myristoylated Acetate inhibit cAMP-dependent protein kinase (PKA) and blocks hyperalgesia produced by spinal administration of 8-bromo-cAMP.
CAS nr:
T21983L
Purity:
98%
Molecular Weight:
SMILES:
Formula:
Pathway:
Tyrosine Kinase/Adaptors
Target:
PKA
